Consultations

A further update by the TGA on the proposed reforms to medicinal cannabis, labelling and packaging requirements.

Proposed amendments to the Poisons Standard. Closing date: 27 January 2020

The closing date for this consultation has been extended until 24 December 2020

The TGA (together with all other working group members) invite interested parties to comment on the document. Closing date: 11 December 2020

Outcome of the Proposed enhancements to adverse event reporting for medical devices consultation paper.

This consultation is for an interim decision to amend the scheduling of nicotine in the current Poisons Standard, following advice sought at the 23 June 2020 meeting of the Advisory Committee on Medicines and Chemicals Scheduling in joint session (Joint ACMS-ACCS #25, June 2020).

This consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the scheduling in the Poisons Standard, following advice sought at the 23-25 June 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS), and the Advisory Committee on Chemicals Scheduling (ACCS).

Consultation: Permissible ingredients annual changes 2020-21

The Secretary invites public submissions on scheduling proposals. Closing date: 28 September 2020

Draft IMDRF document. Closing date: 26 May 2020

The Secretary invites public submissions on scheduling proposals referred to the June 2020 meeting of the Joint ACMS-ACCS. Closing date: 22 May 2020

Consultation extension. Closing date: 18 May 2020

The TGA is seeking feedback for the Scope Regulated Software based products. Closing date: 13 May 2020

Draft IMDRF document. Closing date: 9 May 2020

The Secretary invites public submissions on scheduling proposals referred to the March 2020 meetings of the ACMS, the ACCS, and the Joint ACMS-ACCS. Closing date: 10 February 2020

The Secretary invites public submissions on scheduling proposals referred to the March 2020 meeting of the Joint ACMS-ACCS. Closing date: 10 February 2020

The TGA is seeking comments from interested parties on an update to guidance for the Export of therapeutic goods from Australia.

The closing date of this consultation has been extended. Closing date: 6 December 2019

The final date for public submissions to the consultation has been extended to 31 October 2019

TGA is seeking comments on clarification of the regulation of products used for and by people with disabilities. Closes: 25 October 2019

The Secretary invites public submissions on the scheduling proposals referred to the November 2019 meetings of the ACMS and joint ACCS/ACMS. Closing date: 17 October 2019

The TGA is seeking comments on the proposed changes to the Essential Principles for safety and performance of medical devices. Closing date: 17 October 2019.

These proposed ingredient changes have been reviewed and categorised as being of low-negligible risk. Closing date: 11 October 2019

We are seeking feedback on a proposal to publish the names of excipient ingredients used in therapeutic goods in the public view of the Australian Register for Therapeutic Goods (ARTG).

Draft IMDRF document. Closing date: 3 October 2019